RespireRx Pharmaceuticals Inc. (OTCMKTS:RSPI – Get Free Report) was the target of a significant decrease in short interest during the month of May. As of May 15th, there was short interest totalling 7,500 shares, a decrease of 91.0% from the April 30th total of 83,700 shares. Based on an average daily trading volume, of 7,232,400 […]
Financial Review: RespireRx Pharmaceuticals (OTCMKTS:RSPI) & AnaptysBio (NASDAQ:ANAB) kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.
RespireRx's key asset moves to next stage of NIH initiative proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.
RespireRx Pharmaceuticals Inc. (OTCMKTS:RSPI – Get Free Report) saw a significant increase in short interest during the month of January. As of January 15th, there was short interest totalling 88,500 shares, an increase of 88,400.0% from the December 31st total of 100 shares. Based on an average daily volume of 37,648,000 shares, the days-to-cover ratio […]
RespireRx Pharmaceuticals Inc. (OTCMKTS:RSPI – Get Free Report) was the recipient of a significant increase in short interest in January. As of January 15th, there was short interest totalling 88,500 shares, an increase of 88,400.0% from the December 31st total of 100 shares. Based on an average daily volume of 37,648,000 shares, the short-interest ratio […]